LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2020 - 2024)
LENZ Therapeutics' (LENZ) quarterly Other Non-Current Liabilities came in at $64000.0 in Q3 2024, down 22.89% on a QoQ basis from $83000.0 in Q2 2024.
LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends
LENZ Therapeutics (LENZ) has 5 years of Other Non-Current Liabilities data on file, last reported at $64000.0 in Q3 2024.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $64000.0 in Q3 2024; TTM through Sep 2024 was $64000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $121000.0, down 98.88% from the prior year.
- Other Non-Current Liabilities for Q3 2024 stood at $64000.0, down from $83000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for LENZ reached as high as $10.8 million in Q4 2022 and fell as low as $64000.0 in Q2 2021.
- Historically, Other Non-Current Liabilities has averaged $1.5 million across 5 years, with a median of $116000.0 in 2023.
- Across the five-year window, Other Non-Current Liabilities surged 3676.56% in 2022 and slumped 98.88% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $316000.0 in 2020, then tumbled by 79.75% to $64000.0 in 2021, then soared by 16804.69% to $10.8 million in 2022, then slumped by 98.88% to $121000.0 in 2023, then slumped by 47.11% to $64000.0 in 2024.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $64000.0 in Q3 2024, $83000.0 in Q2 2024, and $111000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 871,000.00 |
| Dec 31, 2022 | 10.82 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 64,000.00 |
| Dec 31, 2020 | 316,000.00 |